Cargando…

Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide. Both genetic and epigenetic changes are involved in esophageal carcinogenesis. CHFR methylation has been found frequently in different cancers and is regarded as a marker of taxane sensitivity. CHFR methylati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Tianyang, Liu, Yang, Gao, Dan, Linghu, Enqiang, Brock, Malcolm V., Yin, Dongtao, Zhan, Qimin, Herman, James G., Guo, Mingzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362483/ https://www.ncbi.nlm.nih.gov/pubmed/25821560

Ejemplares similares

RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel
por: Guo, Jing, et al.
Publicado: (2015)

Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling
por: Zhang, Meiying, et al.
Publicado: (2016)

CHFR and Paclitaxel Sensitivity of Ovarian Cancer
por: Wahner Hendrickson, Andrea E., et al.
Publicado: (2021)

Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development
por: Wang, Ying, et al.
Publicado: (2017)

The hypermethylation of the CDKN2A and CHFR promoter region is a key regulatory mechanism of CDKN2A and CHFR expression in esophageal squamous cell carcinoma
por: Mei, Xinyu, et al.
Publicado: (2019)

CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer
por: Liu, Xuefeng, et al.
Publicado: (2012)

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015)

Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer
por: Maekawa, Hiroshi, et al.
Publicado: (2020)

Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer
por: Jia, Yan, et al.
Publicado: (2015)

Silencing of CHFR Sensitizes Gastric Carcinoma to PARP Inhibitor Treatment
por: Li, Yuan, et al.
Publicado: (2019)

Silencing DACH1 Promotes Esophageal Cancer Growth by Inhibiting TGF-β Signaling
por: Wu, Liang, et al.
Publicado: (2014)

Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis
por: Ding, Yong, et al.
Publicado: (2017)

Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis
por: Zheng, Ruipan, et al.
Publicado: (2017)

Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2021)

Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
por: Wang, Yuzhu, et al.
Publicado: (2017)

Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
por: Wang, Yuzhu, et al.
Publicado: (2018)

The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer
por: Zhang, Xu, et al.
Publicado: (2018)

Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer
por: Cha, Yongjun, et al.
Publicado: (2018)

Chfr and RNF8 synergistically regulate ATM activation
por: Wu, Jiaxue, et al.
Publicado: (2011)

TOPK and PTEN participate in CHFR mediated mitotic checkpoint()
por: Shinde, Swapnil R., et al.
Publicado: (2013)

Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxel or Docetaxel Chemotherapy as Second-Line Therapy in Advanced Esophageal Squamous Cell Carcinoma in China
por: Lin, Ying-tao, et al.
Publicado: (2022)

Peroral Endoscopic Myotomy Can Improve Esophageal Motility in Patients with Achalasia from a Large Sample Self-Control Research (66 Patients)
por: Yao, Shuangzhe, et al.
Publicado: (2015)

Nedaplatin or Oxaliplatin Combined with Paclitaxel and Docetaxel as First-Line Treatment for Patients with Advanced Non-Small Cell Lung Cancer
por: Zhang, Keqian, et al.
Publicado: (2014)

Endoscopic submucosal tunnel dissection with an elastic traction device for a circumferential superficial esophageal neoplasm
por: Ru, Nan, et al.
Publicado: (2023)

The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma
por: Ma, Kai, et al.
Publicado: (2016)

CHFR is important for the first wave of ubiquitination at DNA damage sites
por: Liu, Chao, et al.
Publicado: (2013)

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
por: Derks, Sarah, et al.
Publicado: (2013)

Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
por: Li, Hongxia, et al.
Publicado: (2018)

Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
por: de Leon, Maria C.B., et al.
Publicado: (2013)

New endoscopic classification of esophageal mucosa in achalasia: A predictor for submucosal fibrosis
por: Feng, Xiuxue, et al.
Publicado: (2018)

Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Chen, et al.
Publicado: (2017)

A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer
por: Wang, Guangchao, et al.
Publicado: (2020)

STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
por: Rocha, Sandra M., et al.
Publicado: (2023)

Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia
por: Honda, T, et al.
Publicado: (2004)

CHFR negatively regulates SIRT1 activity upon oxidative stress
por: Kim, Myungjin, et al.
Publicado: (2016)

Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers
por: Zhang, Di, et al.
Publicado: (2017)

Outcomes of super minimally invasive surgery vs. esophagectomy for superficial esophageal squamous cell carcinoma: a single-center study based on propensity score matching
por: Feng, Jiancong, et al.
Publicado: (2022)

Prevention of Esophageal Stricture After Whole Circumferential Endoscopic Resection: A Review for Endoscopists
por: Zou, Jiale, et al.
Publicado: (2022)

Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
por: Guo, Yulin, et al.
Publicado: (2017)

Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oep2m20nfh9bc71u6mr002ok04